Research Directory

Banner year for biotechs

Read more

What entrepreneurs should know about China

Read more

The promise of episomal reprogramming

Read more

Fully human antibodies - myths and magic bullets

Read more

Debate heats up over access to clinical trial data

Read more

The Special Protocol Assessment: Regulatory success is not guaranteed

Read more

The stakes for biopharma from German drug policy

Read more

Johnson & Johnson brings partnering to the frontline

Read more

European biotechs soar

Read more

Cell therapy tested in organ transplantation

Read more